true
Additional Features
Latest news
BD logo
Aug 6, 2026

Revenue of $5.0 billion increased 5.4% as reported, 4.4% FXN GAAP and adjusted diluted EPS from continuing operations of $1.64 and $3.23, respectively Year-to-date cash from continuing operations...

BD logo
Jul 31, 2026

BD (Becton, Dickinson and Company) is voluntarily recalling specific lots of BD® Intraosseous Vascular Access System Needle Sets to the user level. These...

Jul 29, 2026

Collaboration pairs leadership in pharmaceuticals and advanced drug delivery technology to support a consistent, reliable treatment experience for metabolic disease patients. FRANKLIN LAKES, N.J....

See all news releases

Blog
Jul 28, 2026

I’m proud to share the recent launch of BD’s 2025 Sustainability Report, a reflection of the meaningful progress we have made in delivering on our purpose of advancing the world of health. ....

Jul 9, 2026

First-ever disease focused fellowship program supports specialized endovascular training for physicians across Europe By Jane Hart, VP of Clinical Affairs, BD Interventional – Peripheral...

May 11, 2026

How PPAEMA and DEA guidance support secure, accountable medication management for EMS When seconds matter, emergency medical services (EMS) professionals must be empowered to provide lifesaving...

See more blogs